Parkinson's Disease in Patients with Alzheimer's Disease
Overview
Authors
Affiliations
Because patients with Alzheimer's disease often develop clinical manifestations of Parkinson's disease, we examined the substantia nigra in 40 cases of pathologically confirmed Alzheimer's disease for the changes of Parkinson's disease (neuronal loss, Lewy bodies, or neurofibrillary tangles). Eighteen patients had one or more of these changes in the substantia nigra. Subsequently, we reviewed their clinical records and found that rigidity, with or without tremor, had been noted in 13 patients, and nine patients had a second diagnosis of possible or definite Parkinson's disease. Eleven (85%) of these patients had the pathologic changes of Parkinson's disease. These findings suggest that the majority of patients with Alzheimer's disease with extrapyramidal signs have the pathologic changes of Parkinson's disease in the substantia nigra.
Mohammadzadeh N, Wu C, Donahue J, Friedman J Mov Disord Clin Pract. 2024; 11(9):1141-1144.
PMID: 39367741 PMC: 11452794. DOI: 10.1002/mdc3.14149.
Compta Y, Revesz T J Parkinsons Dis. 2020; 11(1):107-121.
PMID: 33325398 PMC: 7990431. DOI: 10.3233/JPD-202323.
Tau reduction does not prevent motor deficits in two mouse models of Parkinson's disease.
Morris M, Koyama A, Masliah E, Mucke L PLoS One. 2011; 6(12):e29257.
PMID: 22206005 PMC: 3242771. DOI: 10.1371/journal.pone.0029257.
Leverenz J, Fishel M, Peskind E, Montine T, Nochlin D, Steinbart E Arch Neurol. 2006; 63(3):370-6.
PMID: 16533963 PMC: 1892620. DOI: 10.1001/archneur.63.3.370.
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.
Tsuang D, Wilson R, Lopez O, Luedecking-Zimmer E, Leverenz J, DeKosky S Neurology. 2005; 64(3):509-13.
PMID: 15699383 PMC: 1487185. DOI: 10.1212/01.WNL.0000150892.81839.D1.